ESTRO 2025 - Abstract Book
S1141
Clinical – Head & neck
ESTRO 2025
40%, and excellent locoregional control rates (local control 88%, regional control 92%). Distant metastasis-free survival was 60% (Figure 1).
Made with FlippingBook Ebook Creator
S1141
Clinical – Head & neck
ESTRO 2025
40%, and excellent locoregional control rates (local control 88%, regional control 92%). Distant metastasis-free survival was 60% (Figure 1).
Made with FlippingBook Ebook Creator